August 12, 2020
Via EDGAR Transmission
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey Gabor
Re: | Selecta Biosciences, Inc. | |
Registration Statement on Form S-3 | ||
Filed August 6, 2020 | ||
Registration No. 333- 241692 |
Dear Mr. Gabor:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on August 14, 2020 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Selecta Biosciences, Inc. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Peter Handrinos of Latham & Watkins LLP, counsel to the Company, at (617) 948-6060, or in his absence, Wesley C. Holmes at (617) 948-6027, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours, | ||
Selecta Biosciences, Inc. | ||
By: | /s/ Carsten Brunn | |
Carsten Brunn, Ph.D. | ||
President and Chief Executive Officer |
cc: | Peter N. Handrinos, Latham & Watkins LLP Wesley C. Holmes, Latham & Watkins LLP |